ACR-SPR-STR practice parameter for the performance of cardiac positron emission tomography - Computed tomography (PET/CT) imaging

Rathan M. Subramaniam, Warren R. Janowitz, Geoffrey B. Johnson, Martin Lodge, Marguerite T. Parisi, Mark R. Ferguson, Jeffrey C. Hellinger, Gregory W. Gladish, Narainder K. Gupta

Research output: Contribution to journalArticle

Abstract

This clinical practice parameter has been developed collaboratively by the American College of Radiology (ACR), the Society for Pediatric Radiology (SPR), and the Society of Thoracic Radiology (STR). This document is intended to act as a guide for physicians performing and interpreting positron emission tomography-computed tomography (PET/CT) of cardiac diseases in adults and children. The primary value of cardiac PET/CT imaging include evaluation of perfusion, function, viability, inflammation, anatomy, and risk stratification for cardiac-related events such as myocardial infarction and death. Optimum utility of cardiac PET/CT is achieved when images are interpreted in conjunction with clinical information and laboratory data. Measurement of myocardial blood flow, coronary flow reserve and detection of balanced ischemia are significant advantages of cardiac PET perfusion studies. Increasingly cardiac PET/CT is used in diagnosis and treatment response assessment for cardiac sarcoidosis.

Original languageEnglish (US)
Pages (from-to)918-927
Number of pages10
JournalClinical Nuclear Medicine
Volume42
Issue number12
DOIs
StatePublished - Dec 1 2017
Externally publishedYes

Fingerprint

Radiology
Thorax
Pediatrics
Perfusion
Sarcoidosis
Heart Diseases
Anatomy
Ischemia
Myocardial Infarction
Inflammation
Physicians
Positron Emission Tomography Computed Tomography
Therapeutics

Keywords

  • ACR practice parameter
  • Cardiac PET/CT
  • Myocardial flow reserve
  • Sarcoid
  • Viability

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

ACR-SPR-STR practice parameter for the performance of cardiac positron emission tomography - Computed tomography (PET/CT) imaging. / Subramaniam, Rathan M.; Janowitz, Warren R.; Johnson, Geoffrey B.; Lodge, Martin; Parisi, Marguerite T.; Ferguson, Mark R.; Hellinger, Jeffrey C.; Gladish, Gregory W.; Gupta, Narainder K.

In: Clinical Nuclear Medicine, Vol. 42, No. 12, 01.12.2017, p. 918-927.

Research output: Contribution to journalArticle

Subramaniam, RM, Janowitz, WR, Johnson, GB, Lodge, M, Parisi, MT, Ferguson, MR, Hellinger, JC, Gladish, GW & Gupta, NK 2017, 'ACR-SPR-STR practice parameter for the performance of cardiac positron emission tomography - Computed tomography (PET/CT) imaging', Clinical Nuclear Medicine, vol. 42, no. 12, pp. 918-927. https://doi.org/10.1097/RLU.0000000000001827
Subramaniam, Rathan M. ; Janowitz, Warren R. ; Johnson, Geoffrey B. ; Lodge, Martin ; Parisi, Marguerite T. ; Ferguson, Mark R. ; Hellinger, Jeffrey C. ; Gladish, Gregory W. ; Gupta, Narainder K. / ACR-SPR-STR practice parameter for the performance of cardiac positron emission tomography - Computed tomography (PET/CT) imaging. In: Clinical Nuclear Medicine. 2017 ; Vol. 42, No. 12. pp. 918-927.
@article{29077f10c4bb4e84b0588acd8f41d1c8,
title = "ACR-SPR-STR practice parameter for the performance of cardiac positron emission tomography - Computed tomography (PET/CT) imaging",
abstract = "This clinical practice parameter has been developed collaboratively by the American College of Radiology (ACR), the Society for Pediatric Radiology (SPR), and the Society of Thoracic Radiology (STR). This document is intended to act as a guide for physicians performing and interpreting positron emission tomography-computed tomography (PET/CT) of cardiac diseases in adults and children. The primary value of cardiac PET/CT imaging include evaluation of perfusion, function, viability, inflammation, anatomy, and risk stratification for cardiac-related events such as myocardial infarction and death. Optimum utility of cardiac PET/CT is achieved when images are interpreted in conjunction with clinical information and laboratory data. Measurement of myocardial blood flow, coronary flow reserve and detection of balanced ischemia are significant advantages of cardiac PET perfusion studies. Increasingly cardiac PET/CT is used in diagnosis and treatment response assessment for cardiac sarcoidosis.",
keywords = "ACR practice parameter, Cardiac PET/CT, Myocardial flow reserve, Sarcoid, Viability",
author = "Subramaniam, {Rathan M.} and Janowitz, {Warren R.} and Johnson, {Geoffrey B.} and Martin Lodge and Parisi, {Marguerite T.} and Ferguson, {Mark R.} and Hellinger, {Jeffrey C.} and Gladish, {Gregory W.} and Gupta, {Narainder K.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1097/RLU.0000000000001827",
language = "English (US)",
volume = "42",
pages = "918--927",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - ACR-SPR-STR practice parameter for the performance of cardiac positron emission tomography - Computed tomography (PET/CT) imaging

AU - Subramaniam, Rathan M.

AU - Janowitz, Warren R.

AU - Johnson, Geoffrey B.

AU - Lodge, Martin

AU - Parisi, Marguerite T.

AU - Ferguson, Mark R.

AU - Hellinger, Jeffrey C.

AU - Gladish, Gregory W.

AU - Gupta, Narainder K.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - This clinical practice parameter has been developed collaboratively by the American College of Radiology (ACR), the Society for Pediatric Radiology (SPR), and the Society of Thoracic Radiology (STR). This document is intended to act as a guide for physicians performing and interpreting positron emission tomography-computed tomography (PET/CT) of cardiac diseases in adults and children. The primary value of cardiac PET/CT imaging include evaluation of perfusion, function, viability, inflammation, anatomy, and risk stratification for cardiac-related events such as myocardial infarction and death. Optimum utility of cardiac PET/CT is achieved when images are interpreted in conjunction with clinical information and laboratory data. Measurement of myocardial blood flow, coronary flow reserve and detection of balanced ischemia are significant advantages of cardiac PET perfusion studies. Increasingly cardiac PET/CT is used in diagnosis and treatment response assessment for cardiac sarcoidosis.

AB - This clinical practice parameter has been developed collaboratively by the American College of Radiology (ACR), the Society for Pediatric Radiology (SPR), and the Society of Thoracic Radiology (STR). This document is intended to act as a guide for physicians performing and interpreting positron emission tomography-computed tomography (PET/CT) of cardiac diseases in adults and children. The primary value of cardiac PET/CT imaging include evaluation of perfusion, function, viability, inflammation, anatomy, and risk stratification for cardiac-related events such as myocardial infarction and death. Optimum utility of cardiac PET/CT is achieved when images are interpreted in conjunction with clinical information and laboratory data. Measurement of myocardial blood flow, coronary flow reserve and detection of balanced ischemia are significant advantages of cardiac PET perfusion studies. Increasingly cardiac PET/CT is used in diagnosis and treatment response assessment for cardiac sarcoidosis.

KW - ACR practice parameter

KW - Cardiac PET/CT

KW - Myocardial flow reserve

KW - Sarcoid

KW - Viability

UR - http://www.scopus.com/inward/record.url?scp=85045669430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045669430&partnerID=8YFLogxK

U2 - 10.1097/RLU.0000000000001827

DO - 10.1097/RLU.0000000000001827

M3 - Article

C2 - 28922191

AN - SCOPUS:85045669430

VL - 42

SP - 918

EP - 927

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 12

ER -